EU/3/15/1474: Orphan designation for the treatment of Stargardt's disease
Ecothiopate iodide
Table of contents
Overview
Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2020 on request of the Sponsor.
On 24 April 2015, orphan designation (EU/3/15/1474) was granted by the European Commission to JJGConsultancy Ltd, United Kingdom, for ecothiopate iodide for the treatment of Stargardt's disease.
Key facts
Active substance |
Ecothiopate iodide
|
Intended use |
Treatment of Stargardt's disease
|
Orphan designation status |
Withdrawn
|
EU designation number |
EU/3/15/1474
|
Date of designation |
24/04/2015
|
Sponsor |
JJGConsultancy Ltd
Sherston House High Street Evercreech Somerset BA4 6HZ United Kingdom Tel. +44 (0)1749 838886 Fax +44 (0)1749 838887 E-mail: jjgconsultancy@btconnect.com |
Review of designation
The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: